Keywords: merck, kgaa, sees, profit, after, tax, soar
Merck KGaA sees profit after tax soar 51% in the 1st qtr of 2006 after strong Rx sales
Article | 08 May 2006
German drugmaker and industrial chemicals group Merck KGaA says that its first-quarter 2006 sales rose 16% on the like, year-ago period, to 1.58 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
